[11C]Osimertinib

osimertinib · AstraZeneca

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [11C]Osimertinib, covering 2023-01-27 to 2023-01-27. Get the full timeline:

Most recent: Clinical Trial Update: Open-label PET Study With [11C]Osimertinib in Patients With EGFRm NSCLC and Brain Metastases [Phase 1]